NHC Webinar Series on Clinical Outcome Assessments. Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference?

Similar documents
Performance Outcome Measures: A Regulatory Perspective

An Approach to Outcome Measure Development: A Regulatory Perspective

Clinical Trial Endpoints from Mobile Technology: Regulatory Considerations September 29, 2016

Patient Reported Outcomes

in alphabetical order:

Study Endpoint Considerations: Final PRO Guidance and Beyond

Update on CDER s Drug Development Tool Qualification Program

Clinician-reported Outcomes (ClinROs), Concepts and Development

Approach to Clinical Trials in Drug Development : Eosinophilic Esophagitis (EoE) Outline. Outline

Patient-Centered Measurement: Innovation Challenge Series

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Lessons learned along the path to qualification of an IBS outcome measure*

Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington

support support support STAND BY ENCOURAGE AFFIRM STRENGTHEN PROMOTE JOIN IN SOLIDARITY Phase 3 ASSIST of the SASA! Community Mobilization Approach

Patient-Focused Drug Development. Theresa Mullin Office of Strategic Programs (OSP) FDA Center for Drug Evaluation and Research (CDER)

Guidelines for Incorporating & Strengthening Perspective-Taking & Self-Authorship into Division of Student Life Programs

Patient-Centered Endpoints in Oncology

Integrating the Patient Perspective Into Value Frameworks

Table of Contents. Clinical Outcome Assessments (COAs): A Conceptual Foundation

Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life

Panelists 11/16/2017. Defining Patient Engagement in Research: A Qualitative Analysis. ISPOR Patient Centered Special Interest Group

Addressing Content Validity of PRO Measures: The Unique Case of Rare Diseases

Update on the Clinical Outcome Assessment Qualification Program and COA Compendium

Overcoming Challenges in Outcome Measurement in Rare Diseases and Pediatric Populations

Advancing the Science of Patient Input in Medical Product R&D: Towards a Research Agenda

Ken Bridges, MD Global Blood Therapeutics, South San Francisco, CA

Hemophilia Patient Organization Self-Assessment

FACILITATOR GUIDE: Communicating with Depressed Patients DocCom Module 27

Building on Our Strengths

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin

The Voice of the Patient FDA s CFS and ME Patient-Focused Drug Development Meeting

Patient Reported Outcomes in Clinical Research. Overview 11/30/2015. Why measure patientreported

OBSERVER-REPORTED OUTCOMES IN CLINICAL TRIALS: CHALLENGES AND SOLUTIONS

Donald L. Patrick PhD, MSPH, Laurie B. Burke RPh, MPH, Chad J. Gwaltney PhD, Nancy Kline Leidy PhD, Mona L. Martin RN, MPA, Lena Ring PhD

NMAC Announces Building Leaders of Color (BLOC)

Estimating sample size for qualitative research in clinical outcome assessment research: one size does not fit all! IP23

Developing a Pediatric COA Measurement Strategy A Case Study in Asthma

Task Force Background Donald Patrick. Appreciation to Reviewers. ISPOR PRO GRP Task Force Reports

MEASURING PATIENT AND OBSERVER-REPORTED OUTCOMES (PROS AND OBSROS) IN RARE DISEASE CLINICAL TRIALS - EMERGING GOOD PRACTICES TASK FORCE

Getting Emerging Planning Professionals Started: What We re All About. Draft for Discussion

What is a Special Interest Group (SIG)?

FACILITATOR GUIDE: Promoting Adherence and Health Behavior Change DocCom Module 16

Intro to epro Part I

Your Voices Amplified

Advancing Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation Day 2

Thank you for joining today, please wait while others sign in.

NAME: If interpreters are used, what is their training in child trauma? This depends upon the agency.

Patient Reported Outcomes Academic Perspective on Clinical Research

Peer Parent Support & Wraparound: Managing the Difference Patricia Miles Brevard Wraparound Conference June 2016

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements

Patient and public involvement. Guidance for researchers

From CF Adult and Family Advisors (AFA) to Community Voice

Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease ReachMD Page 1 of 7

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

Recovery Focus and Introduction to Motivational Interviewing. March 7, 2018 Lisa Kugler, Psy.D.

Symptom Assessment. Jo Thompson Lead Nurse Supportive & Palliative Care Royal Surrey County Hospital, Guildford

CAINS (v1.0) DATE: RATER:

Chapter Quality Network (CQN) Practice Improvement to Address Adolescent Substance Use Project Chapter Application

FDA s GREAT Workshop. Industry Perspective: Development Activities Towards Phase 3 Endpoints. September 19, 2012

Depression: More than just the blues

1st Quarter 2010 Local Release

PATIENT REPORTED OUTCOMES

Submitted to: Re: Comments on CMS Proposals for Patient Condition Groups and Care Episode Groups

IMPACT APA STRATEGIC PLAN

Canadian Mental Health Association

Patient-Reported Outcome Measures

Here for You When You Need Us

Northwest ATTC presents: Treating Co-Occurring Trauma and Addiction

Thinking with the End in Mind: From COA Instrument to Endpoint

PATIENT CENTRIC MEASURES IN HTAs FOR AUTOIMMUNE DISEASES

Improving the Patient Experience

September 30, Eric BASTINGS, MD. Acting Director Division of Neurology Products (DNP) Center for Drug Evaluation and Research (CDER)

Competency Assessment Instrument (CAI): An Instrument to Assess Competencies of Clinicians Providing Treatment to People with Severe Mental Illness

Testing the measurement equivalence of electronically migrated patient-reported outcome (PRO) instruments: Challenges and Solutions

QOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument

The DSM 5 and the Cultural Formulation Interview: What it is and how to implement it ANDRÉS HOYOS, MS, LCSW

Media Guidelines News

MEMBER SATISFACTION SURVEY

UW MEDICINE PATIENT EDUCATION. Support for Care Partners. What should my family and friends know?

BASIC VOLUME. Elements of Drug Dependence Treatment

Speech. Dr. Cindy Forbes. Inaugural Address. President Canadian Medical Association Halifax, NS August 26, Check against delivery

Achieving Operational Excellence in Prospective Observational Research

Patient Reported Outcomes (PROs) in IBD: What Are They and What Does the Clinician Need to Know?

2018 Global Year for Excellence in Pain Education

Scouter Support Training Participant Workbook

FDA s Patient-Focused Drug Development Initiative

Why Tobacco Cessation?

Need to brush up on your hospice and palliative medicine knowledge?

Setting up a Mental Health Support Group

Development of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards

Five Ways to Wellbeing Time to Change Filmed Workshop Supporting Notes

Faculty. W4: Identifying Patients with Rare Disorders Using Administrative Data. O Dan Malone, RPh, PhD University of Arizona

Professional Coach Training Session Evaluation #1

International Clinical Trials Day is on or around 20 May each year, and commemorates the anniversary of the very first clinical trial by James Lind.

Stages of Recovery Interview Schedule

Dementia Signs & Symptoms Guide. Recognizing signs of dementia, getting a diagnosis, and making a plan for the future

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Health Care 3: Partnering In My Care and Treatment

Coaching Patients If I could choose just one thing

Transforming health through IT

Self-directed support

Transcription:

NHC Webinar Series on Clinical Outcome Assessments Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference? NOVEMBER 7, 2018

Outline Why are we having this webinar? Introduction to Clinical Outcome Assessment (COA) Patient centered versus patient reported Examples Q&A Wrap up & announcement of next webinar 3

Why are we having this webinar? FDA s Patient-Focused Drug Development Initiative FDA s Standard Core Clinical Outcome Assessments and Endpoints FDA is seeking information submissions from the public. Information is being solicited to inform planned work to promote development of publicly available standard core sets of Clinical Outcome Assessment (COA) measures for specific disease indications. https://grants.nih.gov/grants/guide/notice-files/not-fd-18-014.html 4

Why are we having this webinar? Patient-centered outcomes research Interest in PROs and patient-centeredness across the healthcare ecosystem Clinical practice guideline development Health care delivery Research Payment models Quality measurement 5

Why are we having this webinar? Ensure NHC membership is prepared to engage in conversations about Clinical Outcome Assessment Clinical Outcome Assessment First in a Webinar series In-person meeting Q2 2019 6

Clinical Outcome Assessments (COAs) FDA definition: measures a patient s symptoms, overall mental state, or the effects of a disease or condition on how the patient functions COAs tell you something about how a patient feels or functions http://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm Walton MK, Powers JA, Hobart J, et al. Clinical outcome assessments: A conceptual foundation Report of the ISPOR Clinical Outcomes Assessment Emerging Good Practices 7 Task Force. Value Health 2015; 18:741-52.

Clinical Outcome Assessment Tools Patient- Reported Outcome Measures (PROs) Clinician- Reported Outcome Measures (ClinROs) Observer- Reported Outcome Measures (ObsROs) Performance Outcome Measures (PerfOs) Report that comes from the patient about the status of a patient s health condition without amendment or interpretation of the patient s report by a clinician or anyone else Report that comes from a trained health-care professional after observation of a patient s health condition Observation by someone other than the patient or a health professional. This may be a parent, spouse, or other non-clinical caregiver who is in a position to regularly observe and report on a specific aspect of the patient s health Based on a task(s) performed by a patient according to instructions that is administered by some one trained such as a health care professional 8

Patient Role Which concepts are important and should be measured? How should items be worded? Are the questions understandable? Do different patients interpret the questions in the same way? Is the recall period appropriate? Does the response scale make sense? What is the best data collection mode? Consultation Concept Elicitation [online]. (2016). York; York Health Economics Consortium; 2016. https://www.yhec.co.uk/glossary/concept-elicitation/ Cognitive Debriefing [online]. (2016). York; York Health Economics Consortium; 2016. https://www.yhec.co.uk/glossary/cognitive-debriefing/ 9

Patient Centered Versus Patient Reported

What is Patient Centered? Any process, program or decision focused on patients in which patients play an active role as meaningfully engaged participants and the central focus is on optimizing use of patient-provided information. Doing things WITH patients, not FOR or TO patients Relies on meaningful engagement 11

What is Patient Reported? A report that comes directly from the patient about the status of a patient's health condition without interpretation of the patient's response by a clinician or anyone else. Self-report or by interview Symptoms or other unobservable concepts known only to the patient (e.g., pain severity or nausea) Patient perspective on functioning or activities that may also be observable by others Source: BEST (Biomarkers, Endpoints and Other Tools) Resource) 12

Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference?

Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference? YES!

Patient-Centered Versus Patient-Reported Outcomes Patient Centered Patient Reported Patient-centered outcomes Outcomes patients report as important to them Both Patient-reported outcomes Outcomes reported only by the patient on how they feel or function 15

Patient Centricity in Patient- Reported Outcome Measures FDA s PRO Guidance (2009) repeatedly states that patient input is critical for developing valid PRO instruments: Without adequate documentation of patient input, a PRO instrument s content validity is likely to be questioned. If symptoms known to be common to the population to be studied in the clinical trial are missing from a measure meant to capture important symptoms in that population, we will question the instrument s content validity. https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf 16

Doesn t that mean all PROs should be patient centered? Theoretically Yes! But, older measures many still in use today may not have been developed based on understanding what is most important to patients Some older measures can be updated to include and emphasize concepts important to patients Use caution and do not assume a PRO tool is patient centered until you understand how it was developed or adapted to focus on what is important to patients 17

Keep in Mind Not all patient-reported outcomes are patient CENTERED. Not all patient-centered outcomes are patient REPORTED. PRO measures can and should be both! 18

Examples

Example #1: Chronic Fatigue Syndrome Voice-of-the-Patient Meeting held in 2013. Patients expressed they would like to have a biomarker for their disease. It would convince their families, friends, and colleagues that they really have an illness and remove the stigma associated with their disease. a) The biomarker is a patient-centered outcome b) The biomarker is a patient-reported outcome c) The biomarker is both a patient-centered and patientreported outcome d) The biomarker is neither a patient-centered nor patient-reported outcome https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm368806.pdf 20

Example #1: Chronic Fatigue Syndrome Voice-of-the-Patient Meeting held in 2013. Patients expressed they would like to have a biomarker for their disease. It would convince their families, friends, and colleagues that they really have an illness and remove the stigma associated with their disease. a) The biomarker is a patient-centered outcome b) The biomarker is a patient-reported outcome c) The biomarker is both a patient-centered and patientreported outcome d) The biomarker is neither a patient-centered nor patient-reported outcome https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm368806.pdf 21

Example #2: Hemophilia A, Hemophilia B, von Willebrand Disease and Other Heritable Bleeding Disorders Voice-of-the-Patient Meeting held in 2014. Patients expressed that joint pain is one of the most significant symptoms associated with their disease. a) Joint pain is a patient-centered outcome b) Joint pain is a patient-reported outcome c) Joint pain is both a patient-centered and patientreported outcome d) Joint pain is neither a patient-centered nor patientreported outcome https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm513311.pdf 22

Example #2: Hemophilia A, Hemophilia B, von Willebrand Disease and Other Heritable Bleeding Disorders Voice-of-the-Patient Meeting held in 2014. Patients expressed that joint pain is one of the most significant symptoms associated with their disease. a) Joint pain is a patient-centered outcome b) Joint pain is a patient-reported outcome c) Joint pain is both a patient-centered and patientreported outcome d) Joint pain is neither a patient-centered nor patientreported outcome https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm513311.pdf 23

Example #3: Non 24-hour sleep-wake disorder Researchers developed a sleep diary to document and quantify sleep and waking behaviors. The items were selected by combining several older instruments. The researchers involved patients as study subjects to test out the diary. a) The diary is a patient-centered outcome measure. b) The diary is a patient-reported outcome measure. c) The diary is both a patient-centered and patientreported outcome measure d) The diary is neither a patient-centered nor patientreported outcome measure Oehrlein EM, Perfetto EM, et al. Patient-Reported Outcome Measures in the FDA Pilot Compendium: Meeting Today s Standards for 24 Patient Engagement in Development? Value Health. DOI: https://doi.org/10.1016/j.jval.2018.01.004

Example #3: Non 24-hour sleep-wake disorder Researchers developed a sleep diary to document and quantify sleep and waking behaviors. The items were selected by combining several older instruments. The researchers involved patients as study subjects to test out the diary. a) The diary is a patient-centered outcome measure. b) The diary is a patient-reported outcome measure. c) The diary is both a patient-centered and patientreported outcome measure d) The diary is neither a patient-centered nor patientreported outcome measure Oehrlein EM, Perfetto EM, et al. Patient-Reported Outcome Measures in the FDA Pilot Compendium: Meeting Today s Standards for 25 Patient Engagement in Development? Value Health. DOI: https://doi.org/10.1016/j.jval.2018.01.004

Patient Role Which concepts are important and should be measured? How should items be worded? Are the questions understandable? Do different patients interpret the questions in the same way? Is the recall period appropriate? Does the response scale make sense? What is the best data collection mode? Consultation Concept Elicitation [online]. (2016). York; York Health Economics Consortium; 2016. https://www.yhec.co.uk/glossary/concept-elicitation/ Cognitive Debriefing [online]. (2016). York; York Health Economics Consortium; 2016. https://www.yhec.co.uk/glossary/cognitive-debriefing/ 26

Questions?

NHC Series on COAs

Please join us December 7 (2pm ET/ 11am PT) for the next webinar in this series! FDA s Roadmap to Patient-Focused Outcome Measurement in Clinical Trials

What aspects of Clinical Outcome Assessment would you like to see covered? Please submit suggestions: http://www.nationalhealthcouncil.org/webinar-followpatient-reported-outcomes-and-patient-centeredoutcomes-there-difference

Eleanor M. Perfetto, PhD, MS Senior Vice President, Strategic Initiatives 202-973-0546 eperfetto@nhcouncil.org

https://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm

https://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm